Stock Market & Financial Investment News

News Breaks November 21, 2012 05:03 EDT SUPN Supernus announces positive Phase 2b results on SPN-810, advances to development Supernus Pharmaceuticals received positive top-line results from its Phase 2b study on SPN-810 for the treatment of impulsive aggression in ADHD patients. The study is a multi-center randomized, double-blind, placebo controlled clinical trial in children 6-12 diagnosed with Attention Deficit and Hyperactivity Disorder, or ADHD, and characterized by impulsive aggression that is not controlled by optimal stimulant and psychosocial treatment. A total of 121 patients were randomized in the study across placebo and three doses of SPN-810. SPN-810 was well tolerated throughout the study across all doses. The two serious adverse events that occurred were not drug related. The company will be analyzing the full data-set in depth, and subsequently planning on meeting with the FDA to discuss next steps in the development program and the design and protocol for Phase III clinical trials. News For SUPN From The Last 14 Days Check below for free stories on SUPN the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. June 17, 2013 12:00 EDT SUPN Options with decreasing implied volatility: NAV SUPN PVH IVR DOLE Subscribe for More Information June 14, 2013 11:14 EDT SUPN Options with decreasing implied volatility: SUPN CTRX NAV ULTA Subscribe for More Information June 13, 2013 11:47 EDT SUPN Options with decreasing implied volatility: MYGN NBG SUPN TIVO ZQK Subscribe for More Information June 11, 2013 11:43 EDT SUPN Options with decreasing implied volatility: SUPN OPK ANN NAV PAY Subscribe for More Information June 10, 2013 11:43 EDT SUPN Options with decreasing implied volatility: CIEN ZQK ANN SUPN VOD Subscribe for More Information 09:04 EDT SUPN Supernus Pharmaceuticals receives tentative approval for Trokendi Subscribe for More Information June 5, 2013 17:13 EDT SUPN OrbiMed Advisors lowers stake in Supernus Pharmaceuticals to 8.07% from 9.85% Subscribe for More Information 13:29 EDT SUPN Options with decreasing implied volatility: INFI SRPT GES SUPN CPRT Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.